150 related articles for article (PubMed ID: 27401140)
1. Adenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and Leukemia.
Whitehill GD; Amarnath S; Muranski P; Keyvanfar K; Battiwalla M; Barrett AJ; Chinnassamy D
Mol Ther; 2016 Sep; 24(9):1655-64. PubMed ID: 27401140
[TBL] [Abstract][Full Text] [Related]
2. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M
Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812
[TBL] [Abstract][Full Text] [Related]
3. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
4. Clinical-scale selective depletion of alloreactive T cells using an anti-CD25 immunotoxin.
Michálek J; Collins RH; Vitetta ES
Neoplasma; 2003; 50(4):296-9. PubMed ID: 12937844
[TBL] [Abstract][Full Text] [Related]
5. Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells.
Distler E; Bloetz A; Albrecht J; Asdufan S; Hohberger A; Frey M; Schnürer E; Thomas S; Theobald M; Hartwig UF; Herr W
Haematologica; 2011 Jul; 96(7):1024-32. PubMed ID: 21486863
[TBL] [Abstract][Full Text] [Related]
6. Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome.
McIver ZA; Melenhorst JJ; Grim A; Naguib N; Weber G; Fellowes V; Khuu H; Stroncek DS; Leitman SF; Battiwalla M; Barrett AJ
Biol Blood Marrow Transplant; 2011 Dec; 17(12):1846-54. PubMed ID: 21684345
[TBL] [Abstract][Full Text] [Related]
7. In vitro methotrexate as a practical approach to selective allodepletion.
Sathe A; Ortega SB; Mundy DI; Collins RH; Karandikar NJ
Biol Blood Marrow Transplant; 2007 Jun; 13(6):644-54. PubMed ID: 17531774
[TBL] [Abstract][Full Text] [Related]
8. Differences in Aspergillus-specific immune recovery between T-cell-replete and T-cell-depleted hematopoietic transplants.
Perruccio K; Topini F; Tosti A; Gazzola MV; Messina C; Martelli MF; Caniglia M; Velardi A; Cesaro S
Eur J Haematol; 2015 Dec; 95(6):551-7. PubMed ID: 25688598
[TBL] [Abstract][Full Text] [Related]
9. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
[TBL] [Abstract][Full Text] [Related]
10. Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation.
Solomon SR; Tran T; Carter CS; Donnelly S; Hensel N; Schindler J; Bahceci E; Ghetie V; Michálek J; Mavroudis D; Read EJ; Vitetta ES; Barrett AJ
Cytotherapy; 2002; 4(5):395-406. PubMed ID: 12473206
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.
Bleakley M; Heimfeld S; Loeb KR; Jones LA; Chaney C; Seropian S; Gooley TA; Sommermeyer F; Riddell SR; Shlomchik WD
J Clin Invest; 2015 Jul; 125(7):2677-89. PubMed ID: 26053664
[TBL] [Abstract][Full Text] [Related]
12. Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings.
Davies JK; Koh MB; Lowdell MW
Biol Blood Marrow Transplant; 2004 Apr; 10(4):259-68. PubMed ID: 15077224
[TBL] [Abstract][Full Text] [Related]
13. Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host disease.
Stuehler C; Mielke S; Chatterjee M; Duell J; Lurati S; Rueckert F; Einsele H; Bargou RC; Topp MS
Blood; 2009 Sep; 114(13):2829-36. PubMed ID: 19657113
[TBL] [Abstract][Full Text] [Related]
14. Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis.
Koh MB; Prentice HG; Lowdell MW
Bone Marrow Transplant; 1999 May; 23(10):1071-9. PubMed ID: 10373075
[TBL] [Abstract][Full Text] [Related]
15. In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation.
Nachbaur D; Eibl B; Kropshofer G; Meister B; Mitterschiffthaler A; Schennach H; Fischer G; Kopp M; Gunsilius E; Gastl G
J Hematother Stem Cell Res; 2002 Aug; 11(4):731-7. PubMed ID: 12201962
[TBL] [Abstract][Full Text] [Related]
16. Depletion of Alloreactive T-Cells by Anti-CD137-Saporin Immunotoxin.
Lee SC; Seo KW; Kim HJ; Kang SW; Choi HJ; Kim A; Kwon BS; Cho HR; Kwon B
Cell Transplant; 2015; 24(6):1167-81. PubMed ID: 24594433
[TBL] [Abstract][Full Text] [Related]
17. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
[TBL] [Abstract][Full Text] [Related]
18. Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation.
Di Ianni M; Falzetti F; Carotti A; Terenzi A; Del Papa B; Perruccio K; Ruggeri L; Sportoletti P; Rosati E; Marconi P; Falini B; Reisner Y; Velardi A; Aversa F; Martelli MF
Best Pract Res Clin Haematol; 2011 Sep; 24(3):459-66. PubMed ID: 21925099
[TBL] [Abstract][Full Text] [Related]
19. Targeting polo-like kinase 1 suppresses essential functions of alloreactive T cells.
Berges C; Chatterjee M; Topp MS; Einsele H
Immunol Res; 2016 Jun; 64(3):687-98. PubMed ID: 26724940
[TBL] [Abstract][Full Text] [Related]
20. [Changes of lymphocyte subsets in acute leukemia patients after HLA-mismatched nonmyeloablative hematopoietic stem cell transplantation].
Hu KX; Guo M; Yu CL; Wang DH; Sun QY; Qiao JH; Liu GX; Liu TQ; Ai HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1527-31. PubMed ID: 20030940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
